News Sanofi cholesterol drug can stay on US market - for now Sales of Praluent can continue during patent case appeal.
News New general manager and diabetes medical leader for Sanofi U... Hugo Fry and Dr Hubert Bland take on new roles at Sanofi UK
News Sanofi's Kevzara gains first approval in Canada Sanofi and Regeneron's new rheumatoid arthritis (RA) drug Kevzara has gained its first global approval in Canada.
News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Court bans US sales of Sanofi cholesterol drug Amgen looks to corner PCSK9 market after patent win.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.